- •CONTENTS
- •PREFACE
- •ABBREVIATIONS
- •GENERAL AND COLORECTAL
- •CASE 1:
- •ANSWER 1
- •CASE 2:
- •ANSWER 2
- •CASE 3:
- •ANSWER 3
- •CASE 4:
- •ANSWER 4
- •CASE 5:
- •ANSWER 5
- •CASE 6:
- •ANSWER 6
- •CASE 7:
- •ANSWER 7
- •CASE 8:
- •ANSWER 8
- •CASE 9:
- •ANSWER 9
- •CASE 10:
- •ANSWER 10
- •CASE 11:
- •ANSWER 11
- •CASE 12:
- •ANSWER 12
- •CASE 13:
- •ANSWER 13
- •CASE 14:
- •ANSWER 14
- •CASE 15:
- •ANSWER 15
- •CASE 16:
- •ANSWER 16
- •CASE 17:
- •ANSWER 17
- •CASE 18:
- •ANSWER 18
- •CASE 19:
- •ANSWER 19
- •CASE 20:
- •ANSWER 20
- •UPPER GASTROINTESTINAL
- •CASE 21:
- •ANSWER 21
- •CASE 22:
- •ANSWER 22
- •CASE 23:
- •ANSWER 23
- •CASE 24:
- •ANSWER 24
- •CASE 25:
- •ANSWER 25
- •CASE 26:
- •ANSWER 26
- •CASE 27:
- •ANSWER 27
- •CASE 28:
- •ANSWER 28
- •CASE 29:
- •ANSWER 29
- •CASE 30:
- •ANSWER 30
- •CASE 31:
- •ANSWER 31
- •CASE 32:
- •ANSWER 32
- •CASE 33:
- •ANSWER 33
- •CASE 34:
- •ANSWER 34
- •CASE 35:
- •ANSWER 35
- •CASE 36:
- •ANSWER 36
- •BREAST AND ENDOCRINE
- •CASE 37:
- •ANSWER 37
- •CASE 38:
- •ANSWER 38
- •CASE 39:
- •ANSWER 39
- •CASE 40:
- •ANSWER 40
- •CASE 41:
- •VASCULAR
- •CASE 42:
- •ANSWER 42
- •CASE 43:
- •ANSWER 43
- •CASE 44:
- •ANSWER 44
- •CASE 45:
- •ANSWER 45
- •CASE 46:
- •ANSWER 46
- •CASE 47:
- •ANSWER 47
- •CASE 48:
- •ANSWER 48
- •CASE 49:
- •ANSWER 49
- •CASE 50:
- •ANSWER 50
- •CASE 51:
- •ANSWER 51
- •CASE 52:
- •ANSWER 52
- •CASE 53:
- •ANSWER 53
- •CASE 54:
- •ANSWER 54
- •CASE 55:
- •ANSWER 55
- •CASE 56:
- •ANSWER 56
- •UROLOGY
- •CASE 57:
- •ANSWER 57
- •CASE 58:
- •ANSWER 58
- •CASE 59:
- •ANSWER 59
- •CASE 60:
- •ANSWER 60
- •CASE 61:
- •ANSWER 61
- •CASE 62:
- •ANSWER 62
- •CASE 63:
- •ANSWER 63
- •CASE 64:
- •ANSWER 64
- •ORTHOPAEDIC
- •CASE 65:
- •ANSWER 65
- •CASE 66:
- •ANSWER 66
- •CASE 67:
- •ANSWER 67
- •CASE 68:
- •ANSWER 68
- •CASE 69:
- •Questions
- •ANSWER 69
- •CASE 70:
- •ANSWER 70
- •CASE 71:
- •ANSWER 71
- •CASE 72:
- •ANSWER 72
- •CASE 73:
- •ANSWER 73
- •CASE 74:
- •ANSWER 74
- •CASE 75:
- •ANSWER 75
- •CASE 76:
- •ANSWER 76
- •CASE 77:
- •ANSWER 77
- •CASE 78:
- •ANSWER 78
- •CASE 79:
- •ANSWER 79
- •CASE 80:
- •ANSWER 80
- •CASE 81:
- •ANSWER 81
- •EAR, NOSE AND THROAT
- •CASE 82:
- •ANSWER 82
- •CASE 83:
- •ANSWER 83
- •CASE 84:
- •ANSWER 84
- •CASE 85:
- •ANSWER 85
- •NEUROSuRGERY
- •CASE 86:
- •ANSWER 86
- •CASE 87:
- •ANSWER 87
- •CASE 88:
- •ANSWER 88
- •CASE 89:
- •ANSWER 89
- •ANAESTHESIA
- •CASE 90:
- •ANSWER 90
- •CASE 91:
- •ANSWER 91
- •CASE 92:
- •ANSWER 92
- •CASE 93:
- •ANSWER 93
- •CASE 94:
- •ANSWER 94
- •POSTOPERATIVE COMPLICATIONS
- •CASE 95:
- •ANSWER 95
- •CASE 96:
- •ANSWER 96
- •CASE 97:
- •ANSWER 97
- •CASE 98:
- •ANSWER 98
- •CASE 99:
- •ANSWER 99
- •CASE 100:
- •ANSWER 100
Breast and Endocrine
CASE 41: a painleSS lump in the neCK
history
A 40-year-old woman has been referred to the surgical outpatients with a painless lump in the neck. She had noticed the lump 2 weeks previously when looking in the mirror. She had not noticed any other lumps and does not complain of any other symptoms. She has not gained or lost any weight recently, and her bowel habit has remained normal.
examination
Examination reveals a solitary 2 × 2-cm swelling to the left of the midline just above the manubrium. The swelling is firm, smooth and fixed. The swelling moves on swallowing, but does not move on protrusion of the tongue. There are no associated palpable lymph glands. General examination reveals no further abnormalities.
INVESTIGATIONS
|
|
Normal |
haemoglobin |
12.0 g/dl |
11.5–16.0 g/dl |
mean cell volume |
77 fl |
76–96 fl |
White cell count |
10.4 × 109/l |
4.0–11.0 × 109/l |
platelets |
250 × 109/l |
150–400 × 109/l |
Sodium |
137 mmol/l |
135–145 mmol/l |
potassium |
3.7 mmol/l |
3.5–5.0 mmol/l |
urea |
5 mmol/l |
2.5–6.7 mmol/l |
Creatinine |
71 μmol/l |
44–80 μmol/l |
tSh |
0.62 mu/l |
0.5–5.7 mu/l |
Free t3 |
3.4 pmol/l |
2.5–5.3 pmol/l |
Free t4 |
19 pmol/l |
9–22 pmol/l |
Questions
•What is the differential diagnosis for a lump in the anterior triangle of the neck?
•Where is this lump likely to be originating from?
•What steps would you take in the assessment of this lump?
•Which factors may suggest malignancy?
•What are the most common types of malignancy?
93
100 Cases in Surgery
ANSWER 41
!Differentials for a swelling in the anterior triangle of the neck
•Multiple: lymph nodes
•Solitary: does it move with swallowing?
•Yes:
−thyroid origin
−thyroglossal cyst (moves with protrusion of the tongue)
•No:
−Salivary gland
−Dermoid cyst
−Carotid body tumour
−lymph node
−branchial cyst
−Cold abscess (tuberculosis)
Clinical examination indicates that the swelling is likely to be a palpable thyroid nodule. The majority of patients are clinically euthyroid and have normal thyroid function. The presence of abnormal thyroid function suggests a benign diagnosis. Factors that increase the suspicion of malignancy include:
•Age younger than 20 years or older than 70 years
•Male sex
•Recent origin and rapid growth or increase in size
•Firm, hard, or immobile nodule
•Presence of cervical lymphadenopathy
•Associated symptoms of dysphagia or dysphonia
•History of neck irradiation
•Prior history of thyroid carcinoma or a positive family history
Less than 20 per cent of thyroid nodules are malignant, with the majority being cystic or benign. Many solitary thyroid nodules are dominant nodules in a multinodular goitre, which carry a 5 per cent risk of malignancy. Ultrasound is used to distinguish between solid and cystic nodules as well as differentiating a solitary nodule from a dominant nodule in a multinodular goitre. Fine-needle aspiration has a high sensitivity and specificity for distinguishing benign from malignant lumps in the thyroid. The main limitation of fine-needle aspiration is in the differentiation of benign follicular adenoma from malignant follicular cancer. If a follicular neoplasm is diagnosed on fine-needle aspiration, the lesion will need to be fully excised to exclude malignancy. Radio-isotope scanning provides a functional assessment of the thyroid nodule, which can be classified as cold or hot. Most solitary thyroid nodules are cold, with a risk of cancer at around 20 per cent.
Table 41.1 Types of thyroid cancer
Type |
Frequency |
Age (years) |
Behaviour |
Prognosis |
Papillary |
70 per cent |
20–40s |
Slow growing, lymphatic |
good, approximately 80 |
|
|
|
spread to nodes |
per cent 10-year survival |
Follicular |
20 per cent |
35–50s |
bloodstream spread, |
good, approximately 60 |
|
|
|
metastasises to lung or |
per cent 10-year survival |
|
|
|
bone |
|
Anaplastic |
5 per cent |
60–70s |
aggressive, local spread |
poor, approximately 10 |
|
|
|
|
per cent 10-year survival |
Medullary |
5 per cent |
Familial |
From parafollicular C |
|
|
|
|
cells, associated with the |
|
|
|
|
multiple endocrine neo- |
|
|
|
|
plasia (men) syndrome |
|
|
|
|
|
|
94
Breast and Endocrine
KEY POINTS
•less than 20 per cent of thyroid nodules are malignant.
•Follicular adenomas should be excised to rule out malignancy.
95
This page intentionally left blank